1994
DOI: 10.1038/bjc.1994.407
|View full text |Cite
|
Sign up to set email alerts
|

Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis

Abstract: The proteolytic modification of plasminogen activator inhibitor 2 (PAI-2) was studied during apoptosis in the human promyelocytic leukaemic NB4 cell line during treatment with the phosphatase inhibitors okadaic acid and calyculin A as well as the protein synthesis inhibitor cycloheximide. The apoptic type of cell death was ascertained by morphological and biochemical criteria. In cell homogenates PAI-2 was probed by [125I]urokinase plasminogen activator (uPA) and detected as a sodium dodecyl sulphate-stable M(… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
31
1

Year Published

1995
1995
2005
2005

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 44 publications
(34 citation statements)
references
References 34 publications
2
31
1
Order By: Relevance
“…Total RNA was prepared from a human promyelocytic leukemia cell line (NB4) treated with the protein phosphatase inhibitor okadaic acid, which recently has been shown to induce apoptotic cell death with internucleosomal DNA fragmentation in this cell type (23). Upon denaturing RNA gel electrophoresis, the band of intact 28S rRNA was diminished and novel distinct bands hybridizing with 28S rRNA probes appeared (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Total RNA was prepared from a human promyelocytic leukemia cell line (NB4) treated with the protein phosphatase inhibitor okadaic acid, which recently has been shown to induce apoptotic cell death with internucleosomal DNA fragmentation in this cell type (23). Upon denaturing RNA gel electrophoresis, the band of intact 28S rRNA was diminished and novel distinct bands hybridizing with 28S rRNA probes appeared (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…For this purpose, 28S rRNA fragmentation was studied in rat thymocytes treated with glucocorticoids (53) or with the phosphatase inhibitor okadaic acid, which is known to be a general inducer of apoptosis (2); in human promyelocytic NB4 cells treated with okadaic acid (23); in primary bovine endothelial cells treated with tumor necrosis factor (TNF), cycloheximide (42), or okadaic acid; and in rat myeloid IPC-81 cells treated with cAMP analogs (27), the phosphatase inhibitor okadaic acid or calyculin A, or cycloheximide or exposed to a cycle of cooling and heating. The specificity of the apoptotic rRNA fragmentation was ensured by studying RNA fragmentation patterns in models of necrotic cell death (induced by sodium azide, isopropanol, or hypotonic lysis).…”
mentioning
confidence: 99%
“…The morphologically altered cells (apoptotic cells) had more condensed and intensely stained nuclear features, often with typical margination of the nuclear chromatin, with or without fragmented nuclei. The fraction of apoptotic cells was determined in randomly selected areas containing approximately 100 cells (range 90 -130) under epifluorescence microscopy using a Leica IRB inverse microscope with  400 magnification essentially as previously described Jensen et al, 1994).…”
Section: Determination Of Cell Deathmentioning
confidence: 99%
“…SERPINB5 is synthesized in two forms originating from single mRNA species, an intracellular nonglycosylated form (46 543 kDa) and an extracellular glycosylated form (60 kDa) (for a review, see (Bachmann, 1995)). During apoptosis, SERPINB5 is modified leading to reduced molecular weight (Jensen et al, 1994). We detected the 47 kDa nonglycosylated (intracellular, lysates) and the 60-70 kDa glycosylated (secreted) forms of SERPINB5 using Western blotting (Figure 4, panel c).…”
Section: Discussionmentioning
confidence: 99%
“…In a rat bladder in vitro model, the importance of the urokinase system for bladder cancer invasion has been demonstrated by using PLAU pathway antagonists (Fujiyama et al, 2001). SERPINB5 can form a complex with PLAU (Jensen et al, 1994). SERPINB5, the surface receptor of PLAU (PLAUR) and the tissue-type plasminogen activator PLAT were overexpressed in clones B, C and D with highest expression in clone B.…”
Section: Discussionmentioning
confidence: 99%